Gwenn Hansen

Company: Nurix Therapeutics

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: KOL Future Advisory Panel 9:30 am

At a time when the TPD community is poised for more clinical success yet continues to battle for available funding to progress this pioneering drug modality, its crucial we heed the knowhow and experience of the field’s thought leaders. Here we have our TPD Future Advisory Panel Where should the field’s focus be on tackling…Read more

day: Day 2 AM